FDA recalls over 89K bottles of nasal spray that may cause ‘adverse’ medical effects during flu season, throw out ASAP
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
FDA Greenlights U.S. Clinical Trial for New Nasal COVID-19 Vaccine
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Daily Mail16d
Are you allergic to your anti-perspirant?
Bleach, toilet cleaners and surface sprays: Allergy UK recommend using eco-friendly products which tend to be fragrant free. Visit www.allergyfoundation.com, or call their helpline on 0208 303 ...
verywellhealth18d
Spravato Nasal Spray Can Now Be Used Alone for Treatment-Resistant Depression
The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.
Medical News Today19d
Nasal vestibulitis: Is it a pimple, and what can I do about it?
In the study, scientists used a spray ... who has allergies, a dry nose, or a sinus infection. With prompt medical treatment, the infection can improve in just a few days. Nasal vestibulitis ...
healthday24d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...
The Daily Beast24d
New Nasal Spray to Treat Depression Gets FDA Approval
Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...
U.S. News & World Report24d
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had ...
Newsweek24d
FDA Approves Nasal Spray for Depression
The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...
New York Post24d
J&J’s ketamine-derived nasal spray approved by FDA to treat depression
The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...
CNN24d
FDA approves standalone use of J&J’s ketamine-derived depression treatment
The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression ...
Gizmodo24d
Ketamine-Derived Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...